Lorazepam and Gablofen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Gablofen (baclofen). Common drug interactions include hypertonia among females and pancreatic carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Gablofen. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Gablofen?

Gablofen has active ingredients of baclofen. eHealthMe is studying from 3,044 Gablofen users. Check the latest studies of Gablofen.

On Jul, 17, 2026

25 people who take Lorazepam and Gablofen together, and have interactions are studied.

Lorazepam and Gablofen drug interactions.

What are the common drug interactions of Lorazepam and Gablofen, by gender? *:

female:

Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Muscular weakness (muscle weakness)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Overdose
Procedural nausea
Procedural vomiting
Device dislocation
Nausea (feeling of having an urge to vomit)
Pain in extremity
Vomiting

male:

Pancreatic carcinoma (pancreatic cancer)
Confusional state
Somnolence (a state of near-sleep, a strong desire for sleep)

What are the common drug interactions of Lorazepam and Gablofen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Confusional state
Somnolence (a state of near-sleep, a strong desire for sleep)

30-39:

Cerebrospinal fluid leakage
Death
Fall
Implant site pain
Abdominal pain
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Procedural nausea
Procedural vomiting
Nausea (feeling of having an urge to vomit)

40-49:

Device failure
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Device dislocation
Dyspnoea (difficult or laboured respiration)
Hallucination (an experience involving the perception of something not present)
Malaise (a feeling of general discomfort or uneasiness)
Asthenia (weakness)
Confusional state
Implant site infection
Muscular weakness (muscle weakness)

50-59:

Death
Osteomyelitis (infection of bone)

60+:

Cystitis (inflammation of the wall of the bladder)
Drug resistance (reduction in effectiveness of a drug)
Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Pocket erosion
Klebsiella test positive
Lethargy (tiredness)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Overdose
Pathogen resistance
Pseudomonas test positive

What are the existing conditions these people have? *

Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 18 people, 72.00%
Pain: 4 people, 16.00%
Cerebral Palsy: 3 people, 12.00%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 2 people, 8.00%
Spinal Cord Trauma: 2 people, 8.00%
Post Laminectomy Syndrome: 2 people, 8.00%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 8.00%
Constipation: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Gablofen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously